TFCP2-rearranged rhabdomyosarcoma with MDM2 amplification: a case report

Background TFCP2 -rearranged rhabdomyosarcoma ( TFCP2 -RMS) is a rare subtype of fusion-related spindle cell RMS characterized by rearrangement of the TFCP2 gene. In addition to TFCP2 gene rearrangement, researchers have identified multiple molecular aberrations. Case presentation Herein, we report a 53-year-old male patient with TFCP2 -RMS and MDM2 gene amplification. The patient underwent surgery at the initial hospital 5 months ago to remove the right ascending pubic ramus and the right acetabular tumor. Recurrence and metastasis were detected 1 month after surgery. Histologically, the tumor showed a mixture of spindle and epithelioid tumor cells, with immature bone trabeculae and osteoclastic giant cells in the background. Tumor cells were positive for CK, Vimentin, MDM2, CDK4, and ALK, focally positive for MyoD1, and negative for SMA, Desmin, and Myogenin. In addition, TFCP2 gene rearrangement and MDM2 gene amplification were detected, and the case was diagnosed as TFCP2 -RMS with MDM2 gene amplification. Unfortunately, the patient died of the disease 9 months after his initial visit. Conclusion TFCP2 -RMS is a rare, highly aggressive malignant tumor with heterogeneity in molecular aberrations, morphology, and immunophenotype. Molecular testing facilitates accurate diagnosis and early clinical management.

Authors

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-16
DOI
https://doi.org/10.3389/fonc.2026.1922695
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

TFCP2-rearranged rhabdomyosarcoma with MDM2 amplification: a case report

Zhongjiao Chen, 徐文峰, Hao Tang, Deyu Guo et al.
2 links
Frontiers in Oncology
Sarcoma Diagnosis and Treatment
article

TFCP2-rearranged rhabdomyosarcoma with MDM2 amplification: a case report

Zhongjiao Chen, 徐文峰, Hao Tang, Deyu Guo, Caijun Huang, Qijian Ying, Ying Chen
article en

Abstract

Background TFCP2 -rearranged rhabdomyosarcoma ( TFCP2 -RMS) is a rare subtype of fusion-related spindle cell RMS characterized by rearrangement of the TFCP2 gene. In addition to TFCP2 gene rearrangement, researchers have identified multiple molecular aberrations. Case presentation Herein, we report a 53-year-old male patient with TFCP2 -RMS and MDM2 gene amplification. The patient underwent surgery at the initial hospital 5 months ago to remove the right ascending pubic ramus and the right acetabular tumor. Recurrence and metastasis were detected 1 month after surgery. Histologically, the tumor showed a mixture of spindle and epithelioid tumor cells, with immature bone trabeculae and osteoclastic giant cells in the background. Tumor cells were positive for CK, Vimentin, MDM2, CDK4, and ALK, focally positive for MyoD1, and negative for SMA, Desmin, and Myogenin. In addition, TFCP2 gene rearrangement and MDM2 gene amplification were detected, and the case was diagnosed as TFCP2 -RMS with MDM2 gene amplification. Unfortunately, the patient died of the disease 9 months after his initial visit. Conclusion TFCP2 -RMS is a rare, highly aggressive malignant tumor with heterogeneity in molecular aberrations, morphology, and immunophenotype. Molecular testing facilitates accurate diagnosis and early clinical management.

Frontiers in OncologyVol. 16
Good health and well-being
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon